Status:
COMPLETED
Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.
Lead Sponsor:
Gérond'if
Conditions:
Symptoms Related to Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose is to study the prevalence of Covid-19 in EHPAD. The primary endpoint will be the combination of PCR results and symptomatology, making it possible to define positive cases in EHPAD, ...
Detailed Description
This study is taking place in several nursing homes in Ile-de-France, which will be recruited at the end of the diagnostic campaign. At the initiative of the ARS Ile-de-France, residents and professi...
Eligibility Criteria
Inclusion
- / Residents of nursing homes in Île-de-France in which systematic Covid-19 screening tests were carried out and agreeing to participate in the study.
- / Professionals in nursing homes in Île-de-France in which systematic screening tests for Covid-19 were carried out and agreeing to participate in the study: nursing assistants, nurses, coordinating doctors, hotel and service agents hygiene, etc.
Exclusion
- / Expression of opposition to the collection of symptoms by professionals, residents or their legal representatives.
- / Subjects who have not had a diagnostic test by RT-PCR.
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 8 2021
Estimated Enrollment :
1059 Patients enrolled
Trial Details
Trial ID
NCT04677283
Start Date
May 7 2020
End Date
July 8 2021
Last Update
February 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Autonomy Department; ARS Île-de-France
Paris, ARS Île-de-France, France, 75019